Netocta-LAR 30mg Injection
Netocta LAR 30mg Injection Netocta LAR 30 mg is a long-acting depot injection containing Octreotide 30 mg. It is a somatostatin analogue supplied as a lyophilized formulation for intramuscular administration. It is used under specialist medical supervision for conditions such as acromegaly and certain neuroendocrine tumors. The formulation is designed for approximately one month of treatment.
Effects & Benefits Helps control excessive secretion of growth hormone and other hormones. Used in the management of acromegaly. May be used for certain neuroendocrine tumors and associated symptoms. Long-acting formulation allows monthly administration.
| Brand | Netocta LAR |
| Storage Temperature | Store refrigerated at 2°C to 8°C. Do not freeze. Protect from light |
| Dosage | As Directed by Specialist |
| Prescription Needed | Yes |
| Composition | Octreotide 30 mg |
| Strength | 30 mg |
| Form | Lyophilized Powder for Injection |
| Pack Size | 1 Combipack |
| Country of Origin | Made in India |
| Manufacturer | Samarth Life Sciences Pvt. Ltd. |
Netocta-LAR 30mg Injection
Netocta LAR 30mg Injection Netocta LAR 30 mg is a long-acting depot injection containing Octreotide 30 mg. It is a somatostatin analogue supplied as a lyophilized formulation for intramuscular administration. It is used under specialist medical supervision for conditions such as acromegaly and certain neuroendocrine tumors. The formulation is designed for approximately one month of treatment.
Effects & Benefits Helps control excessive secretion of growth hormone and other hormones. Used in the management of acromegaly. May be used for certain neuroendocrine tumors and associated symptoms. Long-acting formulation allows monthly administration.
